THANK YOU FOR SUBSCRIBING
Sanitizer Sentinel reminds people to sanitize their hands launched globally after clinical trials at NHS and private medical practices within the UK.
FREMONT, CA: New to market, the patented Sanitizer Sentinel has now officially launched, making it the globe’s first spoken and visual reminder for hand sanitization, with clinical trials already secured at several NHS and private medical practices across the United Kingdom. The Sentinel has 26 selectable messages and sounds in different languages, with toggles to turn the sound and lights on and off, fit for any circumstance. There is also an option to add bespoke or corporate message through a micro SD card. It is seamless to set up and can be implemented anywhere in the world. The volume is also adjustable, making it easy to keep it at a manageable level. The product has been released by Vivian Blick and Neil Norris, based in Gloucestershire, who have a vast knowledge of and experience in the technology and engineering sector.
The Sentinel is a standalone unit that can seamlessly be attached above or close to a hand sanitizer or soap dispenser, with an infra-red sensor that identifies when a person comes within range of the machine. When the sensor is set off, a light will flash, and the Sentinel will play a recorded and selectable message that will remind the passer-by to wash or sanitize their hands. The inclusion of this sanitization unit in public settings will ensure that hand sanitization protocols are followed without a permanent staff member present. It will contribute towards saving many lives by assisting in encouraging handwashing and limiting the spread of COVID-19.
Sanitizer Sentinel project has the potential to save so many lives. The company is excited to be launching the world’s first visual and spoken hand sanitization reminder that saves lives and limits the spread of harmful diseases. It is often easy for people to forget to sanitize their hands, especially when there is no one manning these stations, which removes human error. The interest and take up that the company has already had from both clinical and private organizations alongside global distribution firms shows just how valued this product already is.